Ibex launches study of Galen software for breast cancer

LabPulse.com staff writers
Mar 22, 2022
2016 10 05 17 45 45 493 Breast Cancer 400

Artificial intelligence (AI)-powered cancer diagnostics developer Ibex Medical Analytics has launched a study of its Galen software for breast cancer.

The research will review the clinical performance of the AI-based Galen Breast algorithm, which helps pathologists detect and grade different types of invasive and noninvasive breast cancer, in a retrospective study. Also, researchers will evaluate use of the software's second-read application and digital workflow in clinical use at Hartford HealthCare, which has 400 locations serving 185 towns and cities.

Hartford pathologists may begin using Galen to analyze all cases after they review slides on the microscope.

Latest in Breast Cancer
Breast Cancer Social
Protein expression biomarker may identify likely responders to potential breast cancer drug
March 8, 2023
Breast Cancer2 Social
Agendia MammaPrint UltraLow Risk gene signature recognized in updated NCCN guidelines
February 13, 2023
Breast Cancer 3 D Social
New York State Department of Health approves PreciseDx breast cancer LDT
February 7, 2023
Breast Cancer2 Social
Guardant360 CDx breast cancer liquid biopsy test receives FDA approval as companion diagnostic
January 30, 2023
Related Stories
2021 02 24 22 29 5379 Breast Cancer 20210224225528 20220322220342
Gastric Cancer
Ibex announces study results for breast pathology platform
2019 07 15 18 08 8235 Artificial Intelligence Ai Data 400
Gastric Cancer
Ibex to expand AI use in Medipath laboratories
2018 08 28 18 59 9066 Artificial Intelligence Ai 400
Gastric Cancer
Ibex Medical Analytics gets CE Mark for AI-based gastric test
2020 03 12 20 41 0454 Computer Brain Circuit Ai 400
Pancreatic Cancer
AI spots patients at elevated risk for pancreatic cancer
More in Breast Cancer
Protein expression biomarker may identify likely responders to potential breast cancer drug
In a study, researchers sought to understand the value of RANK and RANKL protein expression as a predictor of breast cancer outcomes and as a therapeutic target.
March 8, 2023
Breast Cancer Social
Agendia MammaPrint UltraLow Risk gene signature recognized in updated NCCN guidelines
The MammaPrint 70-gene signature identifies patients at low or high risk of distant recurrence within five years of a breast cancer diagnosis.
February 13, 2023
Breast Cancer2 Social
New York State Department of Health approves PreciseDx breast cancer LDT
With the approval, PreciseDx can begin testing patient samples using its PDxBr test in the state of New York through its CLIA-certified laboratory.
February 7, 2023
Breast Cancer 3 D Social
Guardant360 CDx breast cancer liquid biopsy test receives FDA approval as companion diagnostic
The Guardant360 CDx blood test uses genomic profiling to identify patients with ESR1 mutations who may benefit from Orserdu therapy.
January 30, 2023
Breast Cancer2 Social
Bionano Genomics announces study findings on optical genome mapping
A study using Bionano Genomics’ OGM shows the method is able to identify homologous recombination deficiency (HRD) in breast cancer samples.
January 13, 2023
Breast Mammo Social
Menarini study demonstrates impact of circulating tumor cell counting on metastatic breast cancer survival
The data demonstrated that a single assessment of circulating tumor cell count by CellSearch before treatment commences may lead to increased overall survival in patients with metastatic breast cancer.
December 22, 2022
Breast Mammo Social
Most Popular
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
FDA reissues EUA for Janssen COVID-19 vaccine, includes warning about risks of myocarditis, pericarditis
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Netherlands researchers combine CRISPR, bioluminescence in proof-of-concept infectious disease test
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
More in Breast Cancer
Molecular signature in study sheds light on adjuvant radiation therapy after breast-conserving surgery
Low scores on an investigational gene molecular signature suggest similar rates of local recurrence whether or not patients received adjuvant radiation therapy after breast-conserving surgery.
December 9, 2022
Radiotherapy Breast Cancer Social
Exact Sciences shares validation data for breast cancer radiation signature at SABCS
The data presented as part of SABCS’s press program were from a meta-analysis of three independent, randomized clinical trials that identified which early-stage breast cancer patients benefited from radiotherapy after breast-conserving surgery.
December 12, 2022
Breast Mammo Social
PathomIQ presents data on AI predictive model at SABCS
The model predicts the response to neoadjuvant chemotherapy in patients with triple-negative breast cancer through extracting morphological features.
December 8, 2022
Artificial Intelligence Ai Head Social
Exact Sciences to present study data on its precision oncology portfolio at SABCS
The firm announced that it will be sharing the data in 10 abstracts and three presentations, highlighting its Oncotype Dx Breast Recurrence Score and Oncomap ExTra tests, as well as offering a look at its tumor-naïve MRD approach.
December 7, 2022
Breast Cancer Cell2 Social
Agendia to present abstracts on gene expression profiling tests at 2022 San Antonio Breast Cancer Symposium
Six studies focus on the impact of Agendia's MammaPrint and BluePrint tests and their ability to unveil the underlying biology of a breast cancer patient’s tumor to inform personalized treatment decisions.
December 6, 2022
Breast Cancer3 Social
At SABCS, University of Rochester professor presents clinical trial results for Biotheranostics Breast Cancer Index
The Breast Cancer Index test is the first biomarker to be evaluated in a cohort from the Suppression of Ovarian Function Trial (SOFT), Hologic noted.
December 7, 2022
Breast Cancer 3 D Social
Page 1 of 11
Next Page